The genetic architecture of mitochondrial dysfunction in Parkinson’s disease
S. B. Larsen, Z. Hanss, R. Krüger · Cell and Tissue Research · 2018 · Review
Full textCC BY
Medicine: papers
Filters2 filters applied
10 papersQuestions on this topic
Cognitive Impairments in Alcohol-Dependent Subjects
Florent Bernardin, Anne Maheut-Bosser, François Paille · Frontiers in Psychiatry · 2014 · Review
Full textCC BY
Caffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms
Xiangpeng Ren, Jiang-Fan Chen · Frontiers in Neuroscience · 2020 · Review
Full textCC BY
Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of Action, Research Application and Future Directions for Its Use
Anna Skrzypczak-Wiercioch, Kinga Sałat · Molecules · 2022 · Review
Full textCC BY
Genetics and Pathogenesis of Parkinson's Syndrome
Hui Ye, Laurie A. Robak, Meigen Yu et al. · Annual Review of Pathology: Mechanisms of Disease · 2023 · Review
Full textCC BY
Molecular and Cellular Mechanisms Affected in ALS
Laura Le Gall, Ekene Anakor, Owen Connolly et al. · Journal of Personalized Medicine · 2020 · Review
Full textCC BY
The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress
Hugo Juárez Olguín, David Calderón Guzmán, Ernestina Hernández García et al. · Oxidative Medicine and Cellular Longevity · 2015 · Review
Full textCC BY
Mechanisms of Endogenous Neuroprotective Effects of Astrocytes in Brain Injury
Michelle A. Bylicky, Gregory P. Mueller, Regina M. Day · Oxidative Medicine and Cellular Longevity · 2018 · Review
Full textCC BY
A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome
Glenn Jennings, Ann Monaghan, Feng Xue et al. · Journal of Clinical Medicine · 2021 · Review
Full textCC BY
Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations
Laura Dresser, Richard Wlodarski, Kourosh Rezania et al. · Journal of Clinical Medicine · 2021 · Review
Full textCC BY